I am a
Home I AM A Search Login

Papers of the Week

Papers: 16 Jul 2022 - 22 Jul 2022

Human Studies


Psoriasis (Auckl)


Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study.


Megna M, Potestio L, Fabbrocini G, Ruggiero A
Psoriasis (Auckl). 2022; 12:205-212.
PMID: 35859710.


Guselkumab safety and efficacy profiles in psoriasis have been showed by VOYAGE (1 and 2) trials. Although trial results have been already previously confirmed by real-life studies, long-term real-life data, and drug survival data about guselkumab are still poor.